BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced …
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
As part of nationwide efforts to improve emergency medical care, researchers at the Mount Sinai Health System, in collaboration with UC San Diego Health, have released a national framework report titled “Promoting Innovations in Emergency Medical Servi…
MILAN & BERKELEY, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/colorishere?src=hash" target="_blank"gt;#colorisherelt;/agt;–At MIDO, February 23-25, EnChroma will demonstrate its cutting-edge glasses for colo…
Researchers have completed the first gene therapy procedure aimed at stopping age-related macular degeneration.The operation was performed at John Radcliffe Hospital, Oxford, England, by Robert MacLaren, FRCOphth, a professor of ophthalmology at the Un…
Abbott has developed an implantable device that continuously monitors the heart rhythm and allows for communication with a clinician via a smartphone. The paperclip-sized device, called the Confirm Rx insertable cardiac monitor (ICM), requires no re-charging and is inserted during an outpatient procedure that is often suture-free. Monitoring a pati (Read more...)